Simplifying Regionalization in Global Trials with Sam Clark, Senior Director of Vendor Management and Procurement at Clinical Ink, and Sudhir Reddy, Esper's CTO

Outcomes Rocket

Esper's platform plays a crucial role in ensuring device security, compliance, and seamless updates, contributing to maintaining trial integrity and patient safety.

In this episode, Sam Clark, Senior Director of Vendor Management and Procurement at Clinical Ink, and Sudhir Reddy, Esper's CTO, talk about the intersection of healthcare, technology, and device management. Sam discusses Clinical Ink’s mission to improve clinical trials through technology and patient-centered research, highlighting the challenges of managing devices across 50 countries and multiple languages, emphasizing the need for tailored processes and secure solutions. Together, Sam and Sudhir explore the evolving role of devices in clinical trials, emphasizing Esper's platform's role in ensuring security, compliance, and updates for maintaining trial integrity and patient safety. They also underscore how the partnership between Clinical Ink and Esper reflects a commitment to innovation and problem-solving, with a vision for future automation and efficiency in clinical trial processes.

Tune in and learn how these collaborations are shaping the future of healthcare device management!

Resources:

• Find out more about the Esper thought leadership series here.
• Connect with and follow Sam Clark on LinkedIn.
• Connect with and follow Sudhir Reddy on LinkedIn and his blogs here.
• Discover more about Clinical Ink on their LinkedIn and website.
• Learn more about Esper on LinkedIn and their website.